Overview

Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether low-dose combine oral contraceptives (COC) containing desogestrel 150 mg and drospirenone 3 mg are effective in the treatment of Premenstrual symptoms.
Phase:
Phase 4
Details
Lead Sponsor:
Chulalongkorn University
Treatments:
Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Combined
Desogestrel
Drospirenone
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Ethinyl Estradiol
Hormones
Polyestradiol phosphate